UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REACTIVE T CELLS FOR TREATMENT OF CANCER

Authors

• Andrew D Weinberg, Earle A. Chiles Research Institute, Providence Cancer InstituteFollow
• Ryan Montier
• Thomas Duhen, Providence St. Joseph HealthFollow
• Rebekka Duhen, Earle A. Chiles Research Institute, Providence Cancer InstituteFollow

Document Type

Patent

Publication Date

2-7-2023

Keywords

oregon

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Comments

Patent Number: US 11,5572,541 B2

Assignee

Providence Health & Services - Oregon; AgonOx, Inc.

Serial Number

16/616,932